Methotrexate Injection BP 25 mg

Methotrexate Injection BP 25 mg is a medication used for various conditions, including certain types of cancer and autoimmune diseases. This solution is administered intra-arterially and is manufactured by Accord Healthcare Inc. in Canada.

Methotrexate Injection BP 25 mg is commonly used in the treatment of certain cancers and autoimmune disorders. It works by interfering with the growth of certain cells in the body. This medication is often prescribed for conditions where other treatments have not been effective. It is important to follow the advice of a healthcare professional when considering the use of Methotrexate Injection BP 25 mg.

Common effects of Methotrexate Injection BP 25 mg may include nausea, vomiting, and fatigue. Some individuals may experience more severe side effects, such as mouth sores or changes in blood cell counts. It is important to monitor for any unusual symptoms and consult a healthcare provider if they occur.

Methotrexate Injection BP 25 mg should be handled with care and stored as directed. It is important to inform your healthcare provider about any allergies or medical conditions before using this medication. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Methotrexate Injection BP 25 mg may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other drugs that affect the immune system. Alcohol consumption should be avoided while using this medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.